活疫苗接种和肝胆风险降低:韩国一项全国性的研究
Junyeol Kim1, Kyeongmin Lee2,3, Jiyeon Oh2,4
1Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
The Korean journal of internal medicine
|September 8, 2025
概括
疹疹 (HZ) 疫苗接种显著降低了老年人肝胆道疾病的风险. 这种带状疹疫苗提供了更广泛的健康益处,降低了肝功能衰竭和肝硬化等肝病的风险.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
背景情况:
- 带状疹疫苗 (HZ) 接种主要用于预防带状疹.
- 系统性免疫调节作用可能会扩大对其他疾病的保护.
- 肝胆道和胰腺疾病是老年人的重大健康问题.
研究的目的:
- 评估活体HZ疫苗是否可以降低长期肝胆道疾病的风险.
- 评估HZ疫苗接种对特定肝脏和胰腺疾病的影响.
主要方法:
- 在韩国进行全国范围的基于人口的队列研究 (n=2,207,784).
- 来自医疗保险,国家健康查和疫苗接种记录 (2012-2021) 的数据合并.
- 1:1倾向得分匹配和考克斯比例危险模型用于分析风险.
主要成果:
- 肝胆疫苗接种与14%的肝胆事件风险降低相关 (aHR为0.86).
- 观察到肝衰竭 (aHR 0.71) 和肝硬化 (aHR 0.74) 的显著风险降低.
- 益处在男性,年轻人和吸烟者中更为明显,持续八年.
结论:
- 疫苗接种表明肝胆道和胰腺疾病的风险显著降低.
- 这些发现支持HZ疫苗接种除了预防带状疹之外的更广泛的健康益处.
- 疫苗接种可能是改善老年人群长期肝脏健康的有价值策略.
相关概念视频
Vaccinations
Overview
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

